Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / M•••••• I•••

M•••••• I•••

Stage unknownCambridge, MABiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
2 rounds
  1. May 8, 2025
    Form D equity offering · $10.0M (form d sold) · 2 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “M•••••• I••• filed Form D: $10,000,000 sold of $10,000,000, Biotechnology”
  2. Jun 23, 2024
    Form D equity offering · $17.0M (form d sold) · 2 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “NeuroBo Pharmaceuticals, Inc. filed Form D: $16,998,224 sold of $16,998,224, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
2 officers, 6 directors
Timeline
2
  1. May 15, 2025
    M•••••• I••• filed Form D: $10,000,000 sold of $10,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Jul 1, 2024
    NeuroBo Pharmaceuticals, Inc. filed Form D: $16,998,224 sold of $16,998,224, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
28 observations
Every observation on this company